The solubilities of indomethacin in various excipients were determined and Labrafac@Lipohile WL1349 (6.91 ± 0.32 mg·g -1 ), Cremophor RH40 (19.98 ± 0.37 mg·g -1 ) and Transcutol P (219.76 ± 4.42 mg·g -1 ) were selected respectively as oil, surfactant and co-surfactant due to their good solubilities. In order to find an optimal range of component proportions to obtain transparent and stable microemulsions, pseudo-ternary phase diagrams were constructed by titration with different surfactant/co-surfactant ratios. The microemulsion areas, which represented the existence field of clear and transparent, stable microemulsions, containing Labrafac@Lipohile WL1349 as oil and the mixing ratio (km) of Cremophor RH40 and Transcutol P fixed, respectively, at 3:1, 1:1 and 1:3 (v/v) in the pseudo-ternary phase-diagrams, were shown in Figure 1 . Larger emulsion region was obtained in the system in which km was at 3:1, compared to km at 1:1 and 1:3. These results indicated that the system containing the mixture of Cremophor RH40/Transcutol P (km =3:1) was selected.
. Pseudo-ternary Phase Diagrams: "Me" represented microemulsion area; (A) the mixing ratio of Cremophor RH40 and Transcutol P was 3:1; (B) the mixing ratio of Cremophor RH40 and Transcutol P was 1:1; (C) the mixing ratio of Cremophor RH40 and Transcutol P was 1:3.
S2. Preparation of the Lipid-Based Formulation of Indomethacin
Labrafac@Lipohile WL1349, Cremophor RH40 and Transcutol P (km = 3:1) were the basic components for the further studies. The formulation was prepared by dissolving indomethacin in Transcutol P and then mixing with Labrafac@Lipohile WL1349 and Cremophor RH40. Finally, a homogenous mixture was obtained. The particle size, emulsifying efficiency and indomethacin solubility were determined, as shown in Supplementary Table S1 . The droplet sizes of four formulations were measured by photon correlation spectroscopy using Zeta-sizer Nano ZS 90 (Malvern Instruments, U.K.). The microscopic droplet of the four nanoemulsions were determined by transmission electron microscopy and showed in Supplementary Figure S2 . All samples were diluted with double-distilled water and the average particle size in nanometers was then measured. Emulsifying efficiency was determined by the progressive titration of formulations containing indomethacin at 37 °C with magnetic force stirring. The time of forming stable emulsion was recorded and the appearance of the stable emulsion was observed. According to the results, Formulation Ⅱ was selected as the optimal one for the smallest droplet size and the better solubility. Table S1 . Self-emulsifying Time, droplet Size, appearance and solubility of indomethacin for the nanoemulsions (mean, n = 5). Figure S2 . The microscopic images of the four formulations. Formulations were showed as labeled and the ruler was in the bottom right corner of the diagram.
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